[ad_1]
The center is conducting an experiment “OPERA” For type 1 diabetes and experience “PHOMS” For multiple sclerosis, these studies would reveal different treatment alternatives for both diseases and determine the appropriate intervention and treatment method..
According to the report from the International Diabetes Federation for the year 2019, the UAE faces one of the highest prevalence rates of diabetes in the world, while the prevalence of multiple sclerosis in the Emirates is approximately 64 cases per 100,000 people, according to a research article published by scientists from Sheikh Khalifa Medical City in 2019.
“The high rates of diabetes and multiple sclerosis pose a serious threat to the lives of citizens and residents of the UAE,” said Dr. Yendri Ventura, immunologist and director general of the Abu Dhabi Stem Cell Center. Lack of treatment alternatives“.
The testing protocols are currently under review by the center’s ethics committee before submitting them to the Ministry of Community Health and Protection and the Abu Dhabi Department of Health to obtain the necessary clearances..
While conducting the experiments, the center will use extracorporeal photopheresis, a treatment technique approved by the U.S. Food and Drug Administration for conditions such as anti-host transplant disease and cutaneous T-cell lymphoma..
Abu Dhabi Stem Cell Center seeks to explore the mechanisms underlying disease immune modulation with that therapeutic alternative and its potential impact on the effectiveness of its use for intervention, thanks to the centre’s extensive research experience and technological advancement ..
And earlier this year, the Abu Dhabi Stem Cell Center became the first research center in the UAE to conduct a clinical trial for a study. Sentad-Covid In April 2020.
In July 2020, the center launched the Abu Dhabi bone marrow transplant program, which treats leukemia patients using stem cells and has so far managed to treat four patients.
.
[ad_2]
Source link
